- Gene Editing
Merck KGaA, Darmstadt, Germany, is a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials. Around 50,000 employees work in 66 countries to improve the quality of life for patients, to foster the success of customers and to help meet global challenges. With extensive expertise in CRISPR gene editing, molecular biology, chemistry, separations, bioreagents, cell culture, biomarker and cellular analysis, Merck continues providing advancements in genome engineering for basic and applied research and manufacturing. Merck KGaA operates as MilliporeSigma in the U.S. and Canada.
AddressFrankfurter Str. 250